Maternal high-fat diet in mice programs emotional behavior in adulthood

Behavioural Brain Research

Volumn 233, Issue 2, 2012, Pages 398-404

  Peleg Raibstein, Daria ^a   Luca, Edlira ^a   Wolfrum, Christian ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Anxiety; Conditioned fear; High fat diet; Maternal nutrition; Mice

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA2; BRAIN DERIVED NEUROTROPHIC FACTOR; SEROTONIN 1A RECEPTOR;

ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR DISORDER; COHORT ANALYSIS; CONDITIONING; CONTROLLED STUDY; EMOTIONALITY; EXPLORATORY BEHAVIOR; FEAR; FEMALE; HIPPOCAMPUS; LACTATION; LIPID DIET; MALE; MATERNAL BEHAVIOR; MATERNAL NUTRITION; MOUSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROGENY; RISK ASSESSMENT;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CONDITIONING, CLASSICAL; DIET, HIGH-FAT; EMOTIONS; EXPLORATORY BEHAVIOR; FEMALE; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MOOD DISORDERS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; TRANSITION TEMPERATURE;

EID: 84862291619     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.05.027     Document Type: Article

References (60)

1. Langley-Evans S.C. Nutritional programming of disease: unravelling the mechanism. Journal of Anatomy 2009, 215:36-51.
2. Boksa P. Animal models of obstetric complications in relation to schizophrenia. Brain Research Reviews 2004, 45:1-17.
3. Kahn S.E., Hull R.L., Utzschneider K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006, 444:840-846.
4. Marx J. Unraveling the causes of diabetes. Science 2002, 296:686-689.
5. Van Gaal L.F., Mertens I.L., De Block C.E. Mechanisms linking obesity with cardiovascular disease. Nature 2006, 444:875-880.
6. Barker D.J. The origins of the developmental origins theory. Journal of Internal Medicine 2007, 261:412-417.
7. Barker D.J., Bull A.R., Osmond C., Simmonds S.J. Fetal and placental size and risk of hypertension in adult life. British Medical Journal 1990, 301:259-262.
8. Eriksson J., Forsen T., Tuomilehto J., Osmond C., Barker D. Size at birth, childhood growth and obesity in adult life. International Journal of Obesity and Related Metabolic Disorders 2001, 25:735-740.
9. McMillen I.C., Adam C.L., Muhlhausler B.S. Early origins of obesity: programming the appetite regulatory system. Journal of Physiology 2005, 565:9-17.
10. Holemans K., Aerts L., Van Assche F.A. Fetal growth restriction and consequences for the offspring in animal models. Journal of the Society for Gynecologic Investigation 2003, 10:392-399.
11. Stocker C.J., Arch J.R., Cawthorne M.A. Fetal origins of insulin resistance and obesity. Proceedings of the Nutrition Society 2005, 64:143-151.
12. Bayol S.A., Farrington S.J., Stickland N.C. A maternal 'junk food' diet in pregnancy and lactation promotes an exacerbated taste for 'junk food' and a greater propensity for obesity in rat offspring. British Journal of Nutrition 2007, 98:843-851.
13. Bilbo S.D., Tsang V. Enduring consequences of maternal obesity for brain inflammation and behavior of offspring. FASEB Journal 2010, 24:2104-2115.
14. Chechi K., Herzberg G.R., Cheema S.K. Maternal dietary fat intake during gestation and lactation alters tissue fatty acid composition in the adult offspring of C57Bl/6 mice. Prostaglandins Leukotrienes and Essential Fatty Acids 2010, 83:97-104.
15. Elahi M.M., Cagampang F.R., Mukhtar D., Anthony F.W., Ohri S.K., Hanson M.A. Long-term maternal high-fat feeding from weaning through pregnancy and lactation predisposes offspring to hypertension, raised plasma lipids and fatty liver in mice. British Journal of Nutrition 2009, 102:514-519.
16. Gregorio B.M., Souza-Mello V., Carvalho J.J., Mandarim-de-Lacerda C.A., Aguila M.B. Maternal high-fat intake predisposes nonalcoholic fatty liver disease in C57BL/6 offspring. American Journal of Obstetrics and Gynecology 2010, 203:495 e1-4958e.
17. Castren E., Rantamaki T. The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Developmental Neurobiology 2010, 70:289-297.
18. Gross C., Zhuang X., Stark K., Ramboz S., Oosting R., Kirby L., et al. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 2002, 416:396-400.
19. Heisler L.K., Chu H.M., Brennan T.J., Danao J.A., Bajwa P., Parsons L.H., et al. Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:15049-15054.
20. Yee B.K., Hauser J., Dolgov V.V., Keist R., Mohler H., Rudolph U., et al. GABA receptors containing the alpha5 subunit mediate the trace effect in aversive and appetitive conditioning and extinction of conditioned fear. European Journal of Neuroscience 2004, 20:1928-1936.
21. Richmond M.A., Murphy C.A., Pouzet B., Schmid P., Rawlins J.N., Feldon J. A computer controlled analysis of freezing behaviour. Journal of Neuroscience Methods 1998, 86:91-99.
22. Sullivan E.L., Grayson B., Takahashi D., Robertson N., Maier A., Bethea C.L., et al. Chronic consumption of a high-fat diet during pregnancy causes perturbations in the serotonergic system and increased anxiety-like behavior in nonhuman primate offspring. Journal of Neuroscience 2010, 30:3826-3830.
23. Bannerman D.M., Deacon R.M., Offen S., Friswell J., Grubb M., Rawlins J.N. Double dissociation of function within the hippocampus: spatial memory and hyponeophagia. Behavioral Neuroscience 2002, 116:884-901.
24. Deacon R.M., Rawlins J.N. Hippocampal lesions, species-typical behaviours and anxiety in mice. Behavioural Brain Research 2005, 156:241-249.
25. Vucetic Z., Kimmel J., Totoki K., Hollenbeck E., Reyes T.M. Maternal high-fat diet alters methylation and gene expression of dopamine and opioid-related genes. Endocrinology 2010, 151:4756-4764.
26. Barkus C., McHugh S.B., Sprengel R., Seeburg P.H., Rawlins J.N., Bannerman D.M. Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion. European Journal of Pharmacology 2010, 626:49-56.
27. Gray J.A., McNaughton N. The neuropsychology of anxiety: reprise. Nebraska Symposium on Motivation 1996, 43:61-134.
28. McNaughton N. Cognitive dysfunction resulting from hippocampal hyperactivity-a possible cause of anxiety disorder. Pharmacology Biochemistry and Behavior 1997, 56:603-611.
29. Suranyi-Cadotte B.E., Bodnoff S.R., Welner S.A. Antidepressant-anxiolytic interactions: involvement of the benzodiazepine-GABA and serotonin systems. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1990, 14:633-654.
30. Barrett J.E., Vanover K.E. 5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions. Psychopharmacology (Berlin) 1993, 112:1-12.
31. Lidov H.G., Molliver M.E. An immunohistochemical study of serotonin neuron development in the rat: ascending pathways and terminal fields. Brain Research Bulletin 1982, 8:389-430.
32. Rentesi G., Antoniou K., Marselos M., Fotopoulos A., Alboycharali J., Konstandi M. Long-term consequences of early maternal deprivation in serotonergic activity and HPA function in adult rat. Neuroscience Letters 2010, 480:7-11.
33. Spinelli S., Chefer S., Carson R.E., Jagoda E., Lang L., Heilig M., et al. Effects of early-life stress on serotonin(1A) receptors in juvenile Rhesus monkeys measured by positron emission tomography. Biological Psychiatry 2010, 67:1146-1153.
34. Rotta L.N., Schmidt A.P., Mello e Souza T., Nogueira C.W., Souza K.B., Izquierdo I.A. Effects of undernutrition on glutamatergic parameters in rat brain. Neurochemical Research 2003, 28:1181-1186.
35. Levay E.A., Paolini A.G., Govic A., Hazi A., Penman J., Kent S. Anxiety-like behaviour in adult rats perinatally exposed to maternal calorie restriction. Behavioural Brain Research 2008, 191:164-172.
36. Holmes A., le Guisquet A.M., Vogel E., Millstein R.A., Leman S., Belzung C. Early life genetic, epigenetic and environmental factors shaping emotionality in rodents. Neuroscience and Biobehavioral Reviews 2005, 29:1335-1346.
37. Bannerman D.M., Rawlins J.N., McHugh S.B., Deacon R.M., Yee B.K., Bast T., et al. Regional dissociations within the hippocampus-memory and anxiety. Neuroscience and Biobehavioral Reviews 2004, 28:273-283.
38. Tapia-Arancibia L., Rage F., Givalois L., Arancibia S. Physiology of BDNF: focus on hypothalamic function. Frontiers in Neuroendocrinology 2004, 25:77-107.
39. Leibrock J., Lottspeich F., Hohn A., Hofer M., Hengerer B., Masiakowski P., et al. Molecular cloning and expression of brain-derived neurotrophic factor. Nature 1989, 341:149-152.
40. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biological Psychiatry 2006, 59:1116-1127.
41. Martinowich K., Manji H., Lu B. New insights into BDNF function in depression and anxiety. Nature Neuroscience 2007, 10:1089-1093.
42. Schmidt H.D., Duman R.S. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behavioural Pharmacology 2007, 18:391-418.
43. Lang U.E., Hellweg R., Kalus P., Bajbouj M., Lenzen K.P., Sander T., et al. Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (Berlin) 2005, 180:95-99.
44. Jiang X., Xu K., Hoberman J., Tian F., Marko A.J., Waheed J.F., et al. BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology 2005, 30:1353-1361.
45. Coupe B., Dutriez-Casteloot I., Breton C., Lefevre F., Mairesse J., Dickes-Coopman A., et al. Perinatal undernutrition modifies cell proliferation and brain-derived neurotrophic factor levels during critical time-windows for hypothalamic and hippocampal development in the male rat. Journal of Neuroendocrinology 2009, 21:40-48.
46. Mayeur S., Silhol M., Moitrot E., Barbaux S., Breton C., Gabory A., et al. Placental BDNF/TrkB signaling system is modulated by fetal growth disturbances in rat and human. Placenta 2010, 31:785-791.
47. Greisen M.H., Altar C.A., Bolwig T.G., Whitehead R., Wortwein G. Increased adult hippocampal brain-derived neurotrophic factor and normal levels of neurogenesis in maternal separation rats. Journal of Neuroscience Research 2005, 79:772-778.
48. O'Sullivan E., Barrett E., Grenham S., Fitzgerald P., Stanton C., Ross R.P., et al. BDNF expression in the hippocampus of maternally separated rats: does Bifidobacterium breve 6330 alter BDNF levels. Beneficial Microbes 2011, 2:199-207.
49. Govindarajan A., Rao B.S., Nair D., Trinh M., Mawjee N., Tonegawa S., et al. Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:13208-13213.
50. Papaleo F., Silverman J.L., Aney J., Tian Q., Barkan C.L., Chadman K.K., et al. Working memory deficits, increased anxiety-like traits, and seizure susceptibility in BDNF overexpressing mice. Learning and Memory 2011, 18:534-544.
51. Pietropaolo S., Paterna J.C., Bueler H., Feldon J., Yee B.K. Bidirectional changes in water-maze learning following recombinant adenovirus-associated viral vector (rAAV)-mediated brain-derived neurotrophic factor expression in the rat hippocampus. Behavioural Pharmacology 2007, 18:533-547.
52. Yee B.K., Zhu S.W., Mohammed A.H., Feldon J. Levels of neurotrophic factors in the hippocampus and amygdala correlate with anxiety- and fear-related behaviour in C57BL6 mice. Journal of Neural Transmission 2007, 114:431-444.
53. Zhu S.W., Yee B.K., Nyffeler M., Winblad B., Feldon J., Mohammed A.H. Influence of differential housing on emotional behaviour and neurotrophin levels in mice. Behavioural Brain Research 2006, 169:10-20.
54. Biggio G., Concas A., Corda M.G., Giorgi O., Sanna E., Serra M. GABAergic and dopaminergic transmission in the rat cerebral cortex: effect of stress, anxiolytic and anxiogenic drugs. Pharmacology & Therapeutics 1990, 48:121-142.
55. Petty F. GABA and mood disorders: a brief review and hypothesis. Journal of Affective Disorders 1995, 34:275-281.
56. Mohler H. The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology 2012, 62:42-53.
57. Mohler H., Fritschy J.M., Luscher B., Rudolph U., Benson J., Benke D. The GABAA receptors from subunits to diverse functions. Ion Channels 1996, 4:89-113.
58. Mohler H., Fritschy J.M., Rudolph U. A new benzodiazepine pharmacology. Journal of Pharmacology and Experimental Therapeutics 2002, 300:2-8.
59. Rudolph U., Mohler H. Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annual Review of Pharmacology and Toxicology 2004, 44:475-498.
60. Low K., Crestani F., Keist R., Benke D., Brunig I., Benson J.A., et al. Molecular and neuronal substrate for the selective attenuation of anxiety. Science 2000, 290:131-134.